NS
CPRX

NBC Securities’s Catalyst Pharmaceutical CPRX Stock Holding History

NBC Securities’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.39K Hold
235
– – ﹤0.01% 1972
2026
Q1 		$5.82K Hold
235
– – ﹤0.01% 2076
2025
Q4 		$5.48K Buy
+235
New +$5.24K ﹤0.01% 2183
2025
Q2 		– Sell
-578
Closed -$14K – 2459
2025
Q1 		$14K Buy
+578
New +$13K ﹤0.01% 1617

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NBC Securities's CPRX Position: Q2 2026 in Review

NBC Securities held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 235 shares worth $7.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1972.

NBC Securities first reported a position in CPRX in Q1 2025 and has held it in 4 quarters since. The position peaked at $14K in Q1 2025. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • NBC Securities held 235 shares of Catalyst Pharmaceutical worth $7.39K as of Q2 2026.
  • NBC Securities left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1972 holding.
  • NBC Securities first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 4 quarters since.
  • NBC Securities's Catalyst Pharmaceutical position peaked at $14K in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.